Romy Chamoun, MD (@romychamoun) 's Twitter Profile
Romy Chamoun, MD

@romychamoun

Gastroenterology Fellow @GW_Gastro | Wifey of @RoyTaoutel 💍 #WomenInMedicine 🌍 🇱🇧

ID: 717825994

calendar_today16-10-2013 16:17:57

1,1K Tweet

1,1K Followers

988 Following

Romy Chamoun, MD (@romychamoun) 's Twitter Profile Photo

Case Studies in GI Motility Disorders: Bloating 101: Low FODMAP vs Rifaximin -My belly 😣,optimizing abdo pain relief in IBS; Dr Deutsch -EoE treat 2 target symps improved but histo unchanged - Amanda Krause,MD Brennan Spiegel, MD, MSHS Panel:Dr Satish Rao,Dr Kongara, Dr Schnoll-Sussman

Case Studies in GI Motility Disorders:
Bloating 101: Low FODMAP vs Rifaximin
-My belly 😣,optimizing abdo pain relief in IBS; Dr Deutsch
-EoE treat 2 target symps improved but histo unchanged - Amanda Krause,MD
<a href="/BrennanSpiegel/">Brennan Spiegel, MD, MSHS</a> 
Panel:Dr Satish Rao,Dr Kongara, Dr Schnoll-Sussman
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

#EbMed25 IBS-C 1st line therapy Darren Brenner MD vs Baha Moshiree MD, MSci, FACG, AGAF 🥗Exercise regularly + low fodmap, high soluble fiber & … a Mediterranean cruise🛳️ Vs Pts often tried lifestyle changes & have debilitating sympt. & need -> 💊Top-down & combo approach … just like in IBD 🙃

#EbMed25 IBS-C 1st line therapy <a href="/dbrennerGIMD/">Darren Brenner MD</a> vs <a href="/BMoshiree/">Baha Moshiree MD, MSci, FACG, AGAF</a> 

🥗Exercise regularly + low fodmap, high soluble fiber &amp; … a Mediterranean cruise🛳️

Vs 

Pts often tried lifestyle changes &amp; have debilitating sympt. &amp; need -&gt; 💊Top-down &amp; combo approach … just like in IBD 🙃
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

#EbMed25 #EoE ✅Dysphagia, CP, heartburn ✅H/o atopic dis. ✅IMPACT👇🏽 ✅Eso bx x2/segmt ✅EREFS👇🏽 Rx: 🔺high dose PPI 🔺1-2 food Elimination (lactose & gluten- 🚫allergy testing) 🔺Dilation 2nd line: 🔺Budesonide OS 2mg BID 🔺Dupilumab 300mg SQ qweek 🔦Monitor Sympt+EGD+Bx

#EbMed25 #EoE
✅Dysphagia, CP, heartburn
✅H/o atopic dis.
✅IMPACT👇🏽
✅Eso bx x2/segmt
✅EREFS👇🏽

Rx: 🔺high dose PPI
🔺1-2 food Elimination (lactose &amp; gluten- 🚫allergy testing)
🔺Dilation
2nd line:
🔺Budesonide OS 2mg BID
🔺Dupilumab 300mg SQ qweek

🔦Monitor Sympt+EGD+Bx
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

#EbMed25 We all see pts w heartburn, nml EGD & no/partial PPI response 🤓The #NERD debate Dr. Schnoll Sussman vs John E. Pandolfino Evidence is power: use your dx 🧰 to dx non-erosive GERD Vs empiric treatment w PCAB #vonoprazan: Relief on day1️⃣ ! 💭What do you do in your practice ?

#EbMed25 We all see pts w heartburn, nml EGD &amp; no/partial PPI response

🤓The #NERD debate <a href="/FeliceSchnoll/">Dr. Schnoll Sussman</a> vs <a href="/JPandolfinoMD/">John E. Pandolfino</a>

Evidence is power: use your dx 🧰 to dx non-erosive GERD

Vs empiric treatment w PCAB #vonoprazan: Relief on day1️⃣ ! 

💭What do you do in your practice ?
Clive Miranda, DO, MSc (@clivejmiranda) 's Twitter Profile Photo

💥 A firecracker of a debate between two Brooklyn heavyweights Dr. Schnoll Sussman and John E. Pandolfino on diagnostic testing vs empiric PCAB in PPI-resistant NERD 🥊 The #GreatDebates of EBMed are unmatched 💪🏻 #EBMed2025 #GITwitter

💥 A firecracker of a debate between two Brooklyn heavyweights <a href="/FeliceSchnoll/">Dr. Schnoll Sussman</a> and <a href="/JPandolfinoMD/">John E. Pandolfino</a> on diagnostic testing vs empiric PCAB in PPI-resistant NERD 🥊

The #GreatDebates of EBMed are unmatched 💪🏻

#EBMed2025 #GITwitter
Mohamad I. Itani, MD (@mitanimd) 's Twitter Profile Photo

#IBD impacts every aspect of life. About IBD: Amber-Writer, Journalist, Podcast Host shares insights as a patient activist: 🤝 Build strong rapport 🧠 Address mental health 💊 Shared decision-making in therapy “IBD touches everything in our lives.” #EBMed2025 #IBDTwitter

#IBD impacts every aspect of life.

<a href="/aboutIBD/">About IBD: Amber-Writer, Journalist, Podcast Host</a> shares insights as a patient activist:

🤝 Build strong rapport
🧠 Address mental health
💊 Shared decision-making in therapy

“IBD touches everything in our lives.”

#EBMed2025 #IBDTwitter
Evidence-Based GI: An ACG Publication (EBGI) (@acg_ebgi) 's Twitter Profile Photo

1/ ⏰ for #EBGI Tweetorial🧵 w/@montalvan214 “Hot Take: Can We Lengthen Surveillance Intervals After EMR With Margin Thermal Ablation?” 📜Summary shorturl.at/otY1N 🎧 shorturl.at/Kxg7j 📰 shorturl.at/grtN2 #GITwitter

1/ ⏰ for #EBGI Tweetorial🧵 w/@montalvan214

“Hot Take: Can We Lengthen Surveillance Intervals After EMR With Margin Thermal Ablation?”

📜Summary shorturl.at/otY1N
🎧 shorturl.at/Kxg7j
📰 shorturl.at/grtN2

#GITwitter
Romy Chamoun, MD (@romychamoun) 's Twitter Profile Photo

So incredibly proud of my sister for making it to this amazing milestone! 💙 All those late nights, stress, and sacrifices have paid off, and I couldn’t be happier for you. You’ve earned every bit of this, and I can’t wait to see you shine even brighter. Love you endlessly!

Romy Chamoun, MD (@romychamoun) 's Twitter Profile Photo

🚨 Week 3 of #CRCAwarenessMonth by Evidence-Based GI: An ACG Publication (EBGI) !🚨 Check out this thread for our first “Q&A with an Expert” session on non-modifiable CRC risk! 🧬 Hereditary Colorectal Cancer Risk with the incredible Dr Swati G. Patel, MD MS 🎤 Moderated by ⭐️Anoushka Dua, MD 🧠 Scroll down to learn more!

Romy Chamoun, MD (@romychamoun) 's Twitter Profile Photo

Check out @kuntalpatelMD’s tweetorial on LNPCP 🔪: ❄️snare vs. 🔥 snare—what’s safer? 🔑 🔥 : 3.9% perf, 7.9% major AEs ❄️ : ZERO perf, 1% major AEs 🔄 Adenoma recurrence: 23.7% wt ❄️vs. 13.8% with 🔥 After 👀this, would you reconsider your approach- ❄️snare or 🔥? 🤔👇

Romy Chamoun, MD (@romychamoun) 's Twitter Profile Photo

🔵#ColonCancerAwarenessMonth🔵 Join us today (03/23)for an exciting Evidence-Based GI: An ACG Publication (EBGI) & #ScopingSundays collaboration! 🔥 💡“From Screening to Resection: Advancing CRC Prevention” 🎤 Moderated by Umer Farooq & Myself😎 ⭐ Featuring expert guest Mohammad Bilal, MD 📅 Don’t miss it!